Terkko Navigator / Autoimmunity Reviews

Exploring IL-17 in spondyloarthritis for development of novel treatments and biomarkers.

Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart?

Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and targeted treatment of autoimmune and inflammatory diseases.

Mesenchymal stromal cells for systemic sclerosis treatment.

Novel positron emission tomography tracers for imaging of rheumatoid arthritis.

Undifferentiated connective tissue disease at risk for systemic sclerosis: Development of a short-term predictive score and a risk stratification tool.

Tolerance and efficacy of anti-TNF currently used for severe non-infectious uveitis.

Association of COVID-19 and Acute Disseminated Encephalomyelitis (ADEM) in the absence of pulmonary involvement.

Novel insights into macrophage diversity in rheumatoid arthritis synovium.

Autoantibodies in COVID-19: frequency and function.

Engineered antigen-specific regulatory T cells for autoimmune skin conditions.

Real life picture of the use of intravenous immunoglobulins in idiopathic inflammatory myopathies: Results of a multicentric study.

The microbiome links between aging and lupus.

The biology, pathogenetic role, clinical implications, and open issues of serum anti-neutrophil cytoplasmic antibodies.

Pathophysiologic role of Interleukin-33/ST2 in Sjögren's syndrome.

Beyond the joints, the extra-articular manifestations in rheumatoid arthritis.

An overview of the NF-kB mechanism of pathophysiology in rheumatoid arthritis, investigation of the NF-kB ligand RANKL and related nutritional interventions.

Efficacy and safety of rituximab in treating patients with Neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis.

Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis: A systematic literature review.

Targeted delivery in scleroderma fibrosis.

Targeted therapies in interstitial lung disease secondary to systemic autoimmune rheumatic disease. Current status and future development.

Rheumatic heart disease: A review of the current status of global research activity.

B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE).

An updated advance of autoantibodies in autoimmune diseases.

Combined Anakinra and Ruxolitinib treatment to rescue extremely ill COVID-19 patients: A pilot study.

The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus.

Posterior reversible encephalopathy syndrome: A neuropsychiatric manifestation of systemic lupus erythematosus.

Spondylitis-psoriasis-enthesitis-enterocolitis-dactylitis-uveitis-peripheral synovitis (SPEED-UP) treatment.

Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review.

Letter to the editor: Frontal fibrosing alopecia: An autoimmune manifestation?

Antiphospholipid antibodies and thrombotic events in COVID-19 patients hospitalized in medicine ward.

SARS-CoV-2, the autoimmune virus.

"Non-criteria" antiphospholipid syndrome: A nomenclature proposal.

Comorbidities and health-related quality of life in Patients with Antineutrophil Cytoplasmic Antibody (ANCA) - associated vasculitis.

Relationship between disease activity, organ damage and health-related quality of life in patients with systemic lupus erythematosus: A systemic review and meta-analysis.

Do we believe in non-radiographic axial spondyloarthritis? A debate.

Profiling and targeting connective tissue remodeling in autoimmunity - A novel paradigm for diagnosing and treating chronic diseases.

Characterization of drug-induced cutaneous lupus: Analysis of 1994 cases using the WHO pharmacovigilance database.

Extracorporeal membrane oxygenation in ANCA-associated vasculitis.

The role of IgE in systemic lupus erythematosus.

Childhood-onset systemic lupus erythematosus-related antiphospholipid syndrome: A multicenter study with 1519 patients.

Parkinson's disease is an autoimmune disease: A reappraisal.

Effect of omega-3 fatty acids on systemic lupus erythematosus disease activity: A systematic review and meta-analysis.

Impact of age at diagnosis in polymyalgia rheumatica: A retrospective cohort study of 218 patients.

The NZB/W F1 mouse model for Sjögren's syndrome: A historical perspective and lessons learned.

Alteration of CXCL8 pathway in the ocular surface of patients with Graves' orbitopathy.

Extensive cutaneous involvement by dermatomyositis: Report of six cases and review of the literature.

Immune checkpoint inhibitors therapies in patients with cancer and preexisting autoimmune diseases: A meta-analysis of observational studies.

COVID-19 and Immune-Mediated Inflammatory Diseases: Why don't our patients get worse?

Overview of IgG4-related aortitis and periaortitis. A decade since their first description.